- Home
- LXEO vs CTM Comparison
LXEO vs CTM Comparison
Compare LXEO & CTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LXEO
- CTM
- Stock Information
- Founded
- LXEO 2017
- CTM 2019
- Country
- LXEO United States
- CTM United States
- Employees
- LXEO N/A
- CTM N/A
- Industry
- LXEO
- CTM EDP Services
- Sector
- LXEO
- CTM Technology
- Exchange
- LXEO Nasdaq
- CTM Nasdaq
- Market Cap
- LXEO 93.9M
- CTM 119.9M
- IPO Year
- LXEO 2023
- CTM N/A
- Fundamental
- Price
- LXEO $4.65
- CTM $1.19
- Analyst Decision
- LXEO Strong Buy
- CTM Strong Buy
- Analyst Count
- LXEO 5
- CTM 1
- Target Price
- LXEO $16.60
- CTM $3.00
- AVG Volume (30 Days)
- LXEO 435.8K
- CTM 3.4M
- Earning Date
- LXEO 08-11-2025
- CTM 07-15-2025
- Dividend Yield
- LXEO N/A
- CTM N/A
- EPS Growth
- LXEO N/A
- CTM N/A
- EPS
- LXEO N/A
- CTM N/A
- Revenue
- LXEO N/A
- CTM $45,094,164.00
- Revenue This Year
- LXEO N/A
- CTM $22.97
- Revenue Next Year
- LXEO N/A
- CTM $3.76
- P/E Ratio
- LXEO N/A
- CTM N/A
- Revenue Growth
- LXEO N/A
- CTM N/A
- 52 Week Low
- LXEO $1.45
- CTM $0.12
- 52 Week High
- LXEO $13.63
- CTM $2.83
- Technical
- Relative Strength Index (RSI)
- LXEO 61.04
- CTM 47.56
- Support Level
- LXEO $3.60
- CTM $1.21
- Resistance Level
- LXEO $4.31
- CTM $1.35
- Average True Range (ATR)
- LXEO 0.33
- CTM 0.11
- MACD
- LXEO -0.00
- CTM -0.02
- Stochastic Oscillator
- LXEO 71.95
- CTM 13.95
About LXEO Lexeo Therapeutics Inc.
Lexeo Therapeutics Inc is a clinical-stage genetic medicines company committed to transforming healthcare by applying pioneering science to fundamentally alter how diseases are treated. The company focuses on preclinical and clinical stage gene therapies, specifically hereditary and acquired diseases with high unmet needs, which represent its sole business segment.
About CTM Castellum Inc.
Castellum Inc is engaged in providing information technology services. The company provides financial services, healthcare, and other users of large data applications with services that include intelligence analysis, software development, software engineering, program management, strategic and mission planning, information assurance, cybersecurity and policy support, data analytics, and MBSE. In addition to constantly innovating and enhancing organic capabilities, Castellum is acquiring technology companies in the areas of cybersecurity, information technology, electronic warfare, information warfare, and information operations with businesses in the defense, federal, civilian, and commercial markets.